Aethlon Medical (NSDQ:AEMD) shares plummetted -44.8% at $1.10 per share today after it announced that it priced an underwritten public offering of common stock worth approximately $5 million. San Diego-based Aethlon intends to use approximately $700,000 of the $5 million in gross proceeds for its planned clinical trials for the Hemopurifier over the next 12 […]

If you don’t understand why the Yankees think so highly of Brett Gardner — and based on my interactions with Yankees fans, a sizable such population exists — I submit Chris Dickerson as the first character witness. Remember Dickerson? You might not if you don’t qualify as a hard-core Yankees fan. Dickerson, an outfielder, played […]

In this podcast and accompanying article, we talked with Dr. Paul Wotton, Chief Executive Officer, Obsidian Therapeutics about the evolution of cancer therapy and new advancements in the space including precision medicine. Our discussion included Obsidian’s cytoDRiVE™ platform that provides a technology, in which the level and timing of protein activity are fully controlled in […]